Analyzing the Development of EGFRvii x MUC1 Bispecific ADC & Its Strategy in Improving Tumor Penetration
9:30 am - Tuesday 9th June 2026
- Introducing EGFRviii and MUC1
- Exploring the dual combination of EGFRviii x MUC1
- Discussing better enrichment of ADC into the TME in the presence of vessel normalizer, PMC-403
